Navigation Links
Fibromyalgia prevalence at 2.1 percent of general German population
Date:2/18/2013

Researchers have determined that fibromyalgia prevalence is 2.1% of the general population in Germany. Results appearing in Arthritis Care & Research, a journal published by Wiley on behalf of the American College of Rheumatology (ACR), suggest that fibromyalgia is a spectrum disorder rather than a categorical illness. Additionally, a number of fibromyalgia cases in the general population satisfy proposed criteria for physical symptom disorderthe presence of one or more physical symptoms that impair function, which cannot be explained by another clinical or psychiatric illness.

Fibromyalgia is a chronic, musculoskeletal syndrome characterized by chronic widespread pain together with fatigue, sleep disturbances, cognitive problems, and multiple somatic symptoms. In 2010 the ACR released modified diagnostic criteria for fibromyalgia, eliminating the tender point count assessment that was part of the 1990 criteria. Shortly after the modified criteria was published it was decided that the widespread pain index and symptom severity score could be combined to form a new measurement of pain and symptom severity termed the polysymptomatic distress scale (PSD).

The lead author of the current study, Dr. Frederick Wolfe with the National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine in Wichita, reported on 2,445 subjects who were randomly selected from the general German population in 2012. The team used the 2010 modified ACR preliminary diagnostic criteria for fibromyalgia to identify patients with the disease.

Findings show fibromyalgia prevalence at 2.1% with occurrence in women and men at 2.4% and 1.8%a difference that was not statistically significant according to researchers. Furthermore, the team found evidence supporting the hypothesis that fibromyalgia is a spectrum disorder and not a distinct disease. Nearly 40% of fibromyalgia patients met the proposed criteria for a physical symptom disorder.

The authors suggest that fibromyalgia should be considered a spectrum or dimensional disorder by giving the range of polysymptomatic distress experienced by patients. A patient with a widespread pain index of 7 or more out of 19 pain sites and symptom severity score of 5 or more out of 12 will have a PSD scale score of at least 12, a cut point below which fibromyalgia criteria will not be met.

"Given the continuum of symptoms in patients, our study provides important evidence supporting fibromyalgia as a spectrum disorder," concludes Dr. Wolfe. "Our findings have important implications for epidemiologic and neurobiologic studies, clinical diagnosis and disease management, along with determining disability in those with fibromyalgia."


'/>"/>

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley
Source:Eurekalert

Related medicine news :

1. Yumi Media Reacts to Study Showing Benefits of Veganism for Fibromyalgia Patients
2. Fibromyalgia Diagnosis Often Missed in Men: Study
3. Men with fibromyalgia often go undiagnosed, Mayo Clinic study suggests
4. Chronic vulvar pain related to irritable bowel syndrome, fibromyalgia and interstitial cystitis
5. 1 in 10 Fibromyalgia Patients Uses Marijuana to Ease Pain
6. Research from the 2013 Genitourinary Cancers Symposium highlights new insights on high-risk prostate cancer prevalence and treatment, compares benefit of surveillance and surgery for management of small kidney tumors
7. High prevalence of drug-resistant MRSA found in nursing homes
8. Autopsy-based study examines prevalence of atherosclerosis among US service members
9. USC, Oxford researchers find high fructose corn syrup-global prevalence of diabetes link
10. CDC and NIH survey provides first report of state-level COPD prevalence
11. Diabetic patients have higher prevalence of hearing impairment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2020)... ... August 31, 2020 , ... Cardiothoracic surgeons at Allegheny ... from Carnegie Mellon University (CMU) to develop a new heart monitoring device designed ... heart surgery. , The AGH/CMU team was recently awarded a “Trailblazer” grant from ...
(Date:8/31/2020)... ... August 31, 2020 , ... Ocean Springs, Mississippi-based pharmaceutical distributor ... first responders across the United States. Since the start of the global COVID-19 ... medical centers , hospitals , firefighters , and public ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... higher-learning opportunities through high-quality, career-relevant, and affordable online education – is proud to ... , Among the first of its kind in the nation, the 60-credit ...
(Date:8/31/2020)... ... , ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis , At this very ... of panic, experiencing deep anxiety, immense stress, and right now are needing serious relief from ... people on the planet are experiencing a great degree of emotional discomfort, be it fear ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde Innovations, LLC, ... with advanced heart failure, today announced that the company has been awarded a ... from the National Heart, Lung, and Blood Institute of the National Institutes of ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... , ... September 02, 2020 ... ... Fight Against Covid-19 , Advanced Penetration Technology, LLC, (APT) a Texas- and ... patients utilizing non-prescription, Over The Counter (OTC) products, was today provided results ...
(Date:9/1/2020)... ... ... While coronavirus cases continue to increase across the country, blood drives are being ... about 80% of blood donations are made at drives hosted by these groups, the ... to ensure blood products are readily available for patients. , Those interested can ...
(Date:8/31/2020)... ... , ... Continuing on its rapid national expansion - ... provider - is proud to announce it has opened doors in Phoenix, Arizona. ... throughout the area. , Germinator provides a 100% safe and non-toxic sanitizing and ...
Breaking Medicine Technology: